News | Radiation Therapy | June 07, 2019

ASTRO Applauds New Prior Authorization Legislation

H.R. 3107 designed to increase transparency in prior authorization process and help curb unnecessary delays for Medicare Advantage patients

ASTRO Applauds New Prior Authorization Legislation

June 7, 2019 — The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices. The society said these practices unnecessarily delay patient access to critical cancer treatments.

The Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107), introduced by Rep. Suzan DelBene (D-Wash.), Rep. Mike Kelly (R-Pa.), Rep. Roger Marshall, M.D., (R-Kan.) and Rep. Ami Bera, M.D., (D-Calif.) is an important first step toward reforming prior authorization practices, according to ASTRO.

ASTRO Chair Paul Harari, M.D., FASTRO, called on Congress to support the bill, which aims to reduce obstacles to high-quality cancer care. “Restrictive prior authorization practices can cause unnecessary, stressful and potentially life-threatening delays for cancer patients,” said Harari. "While the system was designed as a path to streamline and strengthen access to treatments, it is in fact frequently harmful to cancer patients who are prescribed radiation therapy, particularly by wasting precious time and causing immense anxiety. We applaud Reps. DelBene, Kelly, Marshall and Bera for their leadership in introducing this bipartisan legislation to bring needed reform to a broken system.”

In a recent ASTRO nationwide survey of radiation oncologists, more than nine in 10 physicians said that their patients are kept from life-saving treatments due to delays caused by prior authorization, and one-third said the average delay lasts longer than a week. These delays cause added stress and anxiety to patients already concerned about their health, and they are cause for alarm given research that links each week of delay in starting cancer therapy with a 1.2 to 3.2 percent increased risk of death, depending on cancer type.

If passed, this legislation would increase transparency in the prior authorization process and help curb unnecessary delays for patients covered by Medicare Advantage (MA) plans, said ASTRO in the statement. Under the proposed new bill, the MA plans would need to provide relevant information including an annual disclosure of medical treatments subject to prior authorization, the percentage of requests that are approved and denied, and the average time for approval. The legislation also provides for an electronic prior authorization process, which would help streamline decisions and avoid unnecessary delays for certain routine procedures.

Radiation oncology and cancer patients have been particularly hard hit by prior authorization’s unnecessary interference in care decisions, ASTRO said. Radiation oncologists increasingly are restricted from exercising their clinical judgment about what is in the best interest of their patients, yet they are held accountable for the outcomes of treatments where decisions have been taken out of their hands.

The findings from ASTRO’s physician survey align with reports from the American Medical Association (AMA) and American Cancer Society that demonstrate the pervasiveness of prior authorization obstacles throughout the healthcare system. In late February ASTRO joined with the AMA and more than 100 other medical groups calling for prior authorization requirements in Medicare Advantage to align with the Consensus Statement on Improving the Prior Authorization Process authored jointly by leading provider and payer organizations. ASTRO said the new legislation codifies key components of the consensus statement between payers and providers.

For more information: www.astro.org

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Outlook for 2021 and Beyond. As displayed in the figure below, these six market drivers are projected to result in teleradiology reading service volumes increasing by 21% in 2021 and nearly doubling by 2025. Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Feature | Teleradiology | September 15, 2021 | By Arun Gill
The closely tied relationship between...
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Getty Images

Feature | Information Technology | September 14, 2021 | By Jef Williams
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been acquired by Intelerad Medical Systems, a global leader in medical image management solutions. The deal signals an important step in expanding next-generation imaging solutions and resources to help modernise hospital trusts across the UK. 

Getty Images

News | Radiology Business | September 08, 2021
September 8, 2021 — Insignia Medical Systems, a leadi

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...